Sampo's board has approved a €350 million share buyback program, allowing the purchase of up to 45 million A-shares, about 1.69% of total shares. The program runs from May 7 to October 30, 2026, aiming to return capital to shareholders and reduce share count by cancelling bought-back shares. The buybacks will be conducted on several stock exchanges under strict price limits and regulatory compliance. The board may expand the program later if additional capital is raised from selling old financial investments.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...
Holtec Nuclear Corporation has filed a registration statement with the U.S. SEC for a proposed initial public offering (IPO) of its Class A common stock, planning to list on Nasdaq under the symbol "HNUC." The offering details, including share count ...
DeFi platform Aave introduced Stable Vaults, enabling fintechs and payment providers to offer fixed-rate stablecoin yields, enhancing its ecosystem. This launch, alongside the Aave V4 upgrade, increased token trading volume by 14.5% and price by near...
Morgan Stanley has filed to launch Ethereum and Solana ETFs with a competitive 0.14% management fee, aiming to capture market share as crypto ETFs become more commoditized. These ETFs will offer direct token exposure, staking rewards, and institution...
